Monday, April 7, 2014

Sun Pharmaceutical to Buy Ranbaxy in $3.2 Billion Deal - WSJ.com

Sun Pharmaceutical to Buy Ranbaxy in $3.2 Billion Deal - WSJ.com:

"The deal would make Sun Pharma the largest pharmaceutical company in India and the fifth-largest generic drug company in the world. But it would also saddle the Mumbai-based company with the chore of fixing up Ranbaxy's operations and ending restrictions on its U.S. sales.

Before curbs imposed by the U.S. Food and Drug Administration, Ranbaxy earned about 40% of its revenue from the American market. Now, only one Ranbaxy plant, located in the U.S., is producing drugs for U.S. consumption."

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

Enhanced by Zemanta

No comments:

From SkillsPlus International Inc.

Custom Search

Even More Resources, Books, & Things (many from Amazon.com)

FDA, GMPs, QSR, GCP, GLP, GXP:
    GMP Training Gifts & Giveaways